We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Corpay
CPAY
$25.5B
| $5.95M | 0.03% |
23,705
-1,146
| -5% | -$261K |
|
377
VeriSign
VRSN
$25.9B
| $5.92M | 0.03% |
26,187
+6,375
| +32% | +$1.41M |
|
378
Viridian Therapeutics
VRDN
$2.2B
| $5.81M | 0.03% |
244,014
+67,088
| +38% | +$1.72M |
|
379
Eaton
ETN
$150B
| $5.78M | 0.03% |
28,748
+2,796
| +11% | +$492K |
|
|
FITB
380
Fifth Third Bancorp
FITB
$51.3B
| $5.72M | 0.03% |
218,368
-11,965
| -5% | -$308K |
|
381
Commerce Bancshares
CBSH
$8.55B
| $5.69M | 0.03% |
135,189
+74,623
| +123% | +$3.31M |
|
|
CERE
382
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.62M | 0.03% |
176,705
-33,480
| -16% | -$1.03M |
|
383
Teledyne Technologies
TDY
$30.1B
| $5.61M | 0.03% |
13,650
+3,504
| +35% | +$1.45M |
|
384
McKesson
MCK
$101B
| $5.61M | 0.03% |
13,124
+853
| +7% | +$328K |
|
385
Akamai
AKAM
$16.5B
| $5.57M | 0.03% |
61,949
+5,750
| +10% | +$493K |
|
386
NetApp
NTAP
$34.1B
| $5.56M | 0.03% |
72,729
+14,352
| +25% | +$969K |
|
387
Viking Therapeutics
VKTX
$3.84B
| $5.55M | 0.03% |
342,353
-197,959
| -37% | -$4.15M |
|
|
CIVI
388
DELISTED
Civitas Resources
CIVI
| $5.55M | 0.03% |
79,980
-12,344
| -13% | -$854K |
|
389
Edwards Lifesciences
EW
$50B
| $5.53M | 0.03% |
58,644
+3,330
| +6% | +$289K |
|
|
DVAX
390
DELISTED
Dynavax Technologies
DVAX
| $5.52M | 0.03% |
427,076
-113,963
| -21% | -$1.3M |
|
391
Delek US
DK
$4.15B
| $5.51M | 0.03% |
230,254
-44,647
| -16% | -$1.01M |
|
392
Principal Financial Group
PFG
$24.5B
| $5.5M | 0.03% |
72,489
-4,194
| -5% | -$302K |
|
393
First Solar
FSLR
$22.1B
| $5.46M | 0.03% |
28,708
+7,264
| +34% | +$1.44M |
|
394
Nasdaq
NDAQ
$53.2B
| $5.42M | 0.03% |
108,641
-5,620
| -5% | -$304K |
|
395
Humana
HUM
$44B
| $5.42M | 0.03% |
12,112
+937
| +8% | +$472K |
|
396
Altria Group
MO
$113B
| $5.41M | 0.03% |
119,407
+11,422
| +11% | +$517K |
|
397
FNB Corp
FNB
$6.76B
| $5.4M | 0.03% |
471,895
+192,362
| +69% | +$2.17M |
|
398
Tyler Technologies
TYL
$13.3B
| $5.38M | 0.03% |
12,927
+2,426
| +23% | +$934K |
|
399
Magnolia Oil & Gas
MGY
$5.93B
| $5.33M | 0.03% |
254,869
-51,467
| -17% | -$1.06M |
|
400
Editas Medicine
EDIT
$413M
| $5.29M | 0.03% |
642,191
-42,161
| -6% | -$367K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.